Enter your terms above and click the 'Search' button.

Showing articles 0 to 6 of 6 Filter Applied: immune checkpoint inhibitors (Click to remove) Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Melanoma Neurol 101:e2472-e2482, Pepys,J.,et al, 2023 A 48-Year-Old Woman with 6 Months of Vivid Visual Hallucinations Neurol 99:166-171, Kizza, J.,et al, 2022 Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions Ann Neurol 89:1255-1256, Lambert, N.,et al, 2021 Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors Neurol 97:e191-e202, Nersesjan, V.,et al, 2021 Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma Case Rep Neurol Med 2018;doi:10.1155/2018/2548528, Shah, S.,et al, 2018 Showing articles 0 to 6 of 6